Changeflow GovPing Healthcare & Life Sciences CAMP Receptor Protein Mutant Patent EP3686214A1...
Routine Notice Added Final

CAMP Receptor Protein Mutant Patent EP3686214A1 by CJ Cheiljedang

Favicon for changeflow.com EPO Patent Bulletin - Peptides (C07K)
Published
Detected
Email

Summary

The European Patent Office published EP3686214A1, a patent application for a CAMP Receptor Protein Mutant and L-Amino Acid Production Method using the same, filed by CJ Cheiljedang Corporation. The application was published on April 15, 2026, designating 37 contracting states across Europe including Germany, France, the United Kingdom, Italy, and Spain. Five inventors are named: CHEONG Ki Yong, YOO Hyeryun, SEO Chang Il, LEE Jaemin, and CHO Seung Hyun.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Peptides (C07K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 46 changes logged to date.

What changed

The EPO published EP3686214A1, a patent application by CJ Cheiljedang Corporation covering a CAMP Receptor Protein Mutant and its use in L-amino acid production. The publication includes IPC classifications in C07K (peptides), C12N (microorganisms/c12P (fermentation), and C12R (microorganism-specific classifications). Designated contracting states span the majority of European jurisdictions.

Patent applicants and biotechnology firms working with cAMP receptor protein engineering or amino acid biosynthesis should monitor the EPO register for substantive examination outcomes, potential oppositions, and national phase entry deadlines in their jurisdictions of interest.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

CAMP RECEPTOR PROTEIN MUTANT AND L-AMINO ACID PRODUCTION METHOD USING SAME

Publication EP3686214A1 Kind: A1 Apr 15, 2026

Applicants

CJ Cheiljedang Corporation

Inventors

CHEONG, Ki Yong, YOO, Hyeryun, SEO, Chang ll, LEE, Jaemin, CHO, Seung Hyun

IPC Classifications

C07K 14/245 20060101AFI20260309BHEP C12N 15/70 20060101ALI20260309BHEP C12P 13/22 20060101ALI20260309BHEP C12P 13/08 20060101ALI20260309BHEP C12P 13/04 20060101ALI20260309BHEP C12R 1/19 20060101ALI20260309BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Notice
Branch
International
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP3686214A1

Who this affects

Applies to
Pharmaceutical companies Manufacturers
Industry sector
3254.1 Biotechnology
Activity scope
Patent publication Biotech research
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Biotechnology Pharmaceuticals

Get alerts for this source

We'll email you when EPO Patent Bulletin - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!